These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 14998423)

  • 21. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative bioequivalence studies of tramadol hydrochloride sustained-release 200 mg tablets.
    Khandave SS; Sawant SV; Joshi SS; Bansal YK; Kadam SS
    Drug Des Devel Ther; 2010 Nov; 4():367-74. PubMed ID: 21151623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic assessment of a fast-release orodispersible tramadol tablet compared to a conventional tramadol capsule.
    Tagarro I; Vauzelle-Kervroedan F; Díez MC
    Arzneimittelforschung; 2004; 54(5):293-7. PubMed ID: 15212192
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Importance of the formulation for a chronopharmacologically optimised way of pain therapy. Results of a comparative bioavailability study of tramadol extended-release capsules after single-dose evening versus morning administration].
    Warnke A; Schug B; Vanderbist F; Blume H
    MMW Fortschr Med; 2008 Apr; 150 Suppl 1():36-42. PubMed ID: 18540331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biopharmaceutical evaluation of new slow release tablets obtained by hot tableting of coated pellets with tramadol hydrochloride.
    Szkutnik-Fiedler D; Sawicki W; Balcerkiewicz M; Mazgalski J; Grabowski T; Grześkowiak E
    Acta Pol Pharm; 2014; 71(5):813-20. PubMed ID: 25362810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative pharmacokinetics of a once-daily tramadol extended-release tablet and an immediate-release reference product following single-dose and multiple-dose administration.
    Karhu D; Fradette C; Potgieter MA; Ferreira MM; Terblanché J
    J Clin Pharmacol; 2010 May; 50(5):544-53. PubMed ID: 20051587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Criteria to assess in vivo performance of sustained release products: application to diltiazem formulations.
    Bialer M; Sussan S; Abu Salach O; Danenberg HD; Ben-David J; Gibor Y; Laor A
    J Pharm Sci; 1995 Oct; 84(10):1160-3. PubMed ID: 8801328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the pharmacokinetics, clinical efficacy, and tolerability of once-daily tramadol tablets with normal release tramadol capsules.
    Bodalia B; McDonald CJ; Smith KJ; O'Brien C; Cousens L
    J Pain Symptom Manage; 2003 Feb; 25(2):142-9. PubMed ID: 12590030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bioequivalence evaluation of single doses of two tramadol formulations: a randomized, open-label, two-period crossover study in healthy Brazilian volunteers.
    Silva Mde F; Schramm SG; Kano EK; Mori Koono EE; Porta V; dos Reis Serra CH
    Clin Ther; 2010 Apr; 32(4):758-65. PubMed ID: 20435245
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained relief of chronic pain. Pharmacokinetics of sustained release morphine.
    Gourlay GK
    Clin Pharmacokinet; 1998 Sep; 35(3):173-90. PubMed ID: 9784932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of tramadol human pharmacokinetics and safety after co-administration of magnesium ions in randomized, single- and multiple-dose studies.
    Rudzki PJ; Jarus-Dziedzic K; Filist M; Gilant E; Buś-Kwaśnik K; Leś A; Sasinowska-Motyl M; Nagraba Ł; Bujalska-Zadrożny M
    Pharmacol Rep; 2021 Apr; 73(2):604-614. PubMed ID: 33686610
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development, Physicochemical Characteristics and Pharmacokinetics of a New Sustained-Release Bilayer Tablet Formulation of Tramadol with an Immediate-Release Component for Twice-Daily Administration.
    Ishitsubo N; Oguro S; Shimahashi H; Kawanishi M; Adachi T; Mitsuda K; Ishibashi N
    Eur J Drug Metab Pharmacokinet; 2024 Jan; 49(1):87-100. PubMed ID: 38064122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study.
    Cebrecos J; Carlson JD; Encina G; Lahjou M; Sans A; Sust M; Vaqué A; Morte A; Gascón N; Plata-Salamán C
    Clin Ther; 2021 Jun; 43(6):1051-1065. PubMed ID: 34167827
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast.
    Schug BS; Brendel E; Chantraine E; Wolf D; Martin W; Schall R; Blume HH
    Br J Clin Pharmacol; 2002 Jun; 53(6):582-8. PubMed ID: 12047482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-dose pharmacokinetics of co-crystal of tramadol-celecoxib: Results of a four-way randomized open-label phase I clinical trial in healthy subjects.
    Videla S; Lahjou M; Vaqué A; Sust M; Encabo M; Soler L; Sans A; Sicard E; Gascón N; Encina G; Plata-Salamán C
    Br J Clin Pharmacol; 2017 Dec; 83(12):2718-2728. PubMed ID: 28810061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
    Kumar P; Singh S; Mishra B
    Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
    Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
    Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics and Safety of Levetiracetam Extended-Release Tablets and Relative Bioavailability Compared with Immediate-Release Tablets in Healthy Chinese Subjects.
    Wang M; Wang M; Zhang Q; Zong S; Lv C
    Eur J Drug Metab Pharmacokinet; 2018 Aug; 43(4):405-413. PubMed ID: 29383569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single- and multiple-dose pharmacokinetic studies of tramadol immediate-release tablets in children and adolescents.
    Vandenbossche J; Richards H; Solanki B; Van Peer A
    Clin Pharmacol Drug Dev; 2015; 4(3):184-92. PubMed ID: 27140798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The relative bioavailability of morphine sulfate and naltrexone hydrochloride extended release capsules (EMBEDA®) and an extended release morphine sulfate capsule formulation (KADIAN®) in healthy adults under fasting conditions.
    Johnson FK; Ciric S; Boudriau S; Kisicki JC; Stauffer J
    Am J Ther; 2011 Jan; 18(1):2-8. PubMed ID: 20864883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.